ReviewHepatobiliary surgery and nutrition2016
Living donor liver transplantation in Taiwan-challenges beyond surgery.
Review in Hepatobiliary surgery and nutrition, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Secular trend in universal hepatocellular carcinoma prevention: Taiwan, Poland, and Belgium experience.World journal of gastrointestinal oncology · 2025Article
- Developing an Adult Living Donor Liver Transplant Program in Western Europe: The Rotterdam Experience.Transplant international : official journal of the European Society for Organ Transplantation · 2025Article
- A single center analysis of long-term outcomes and survival related risk factors in liver retransplantation.Hepatobiliary surgery and nutrition · 2024Article
- Usefulness of Diffusion-Weighted Imaging in Evaluating Acute Cellular Rejection and Monitoring Treatment Response in Liver Transplant Recipients.Diagnostics (Basel, Switzerland) · 2024Article
- Survival Rate of Liver Transplantation in Asia: A Systematic Review and Meta-Analysis.Iranian journal of public health · 2022Review
- The Post-Traumatic Growth of Primary Caregivers of Patients after Liver Transplantation.Healthcare (Basel, Switzerland) · 2022Article
- Living-Donor Liver Transplantation for Hepatocellular Carcinoma: Impact of the MELD Score and Predictive Value of NLR on Survival.Current oncology (Toronto, Ont.) · 2022Article
- Non-Contrast-Enhanced and Contrast-Enhanced Magnetic Resonance Angiography in Living Donor Liver Vascular Anatomy.Diagnostics (Basel, Switzerland) · 2022Article
- Initiation of Liver Transplant in Nepal: A Milestone.Journal of transplantation · 2022Article
- Comparative analysis of the drug-drug interaction between immunosuppressants, safety and efficacy of rifabutin from rifampicin-based Anti-TB treatment in living donor liver transplant recipients with active tuberculosis.Biomedical journal · 2021Article
- Circuitous Path to Live Donor Liver Transplantation from the Coordinator's Perspective.Journal of personalized medicine · 2021Article
- Sequential Organ Failure Assessment (SOFA) Score-Based Factors Predict Early Mortality in High-Risk Patients with Living Donor Liver Transplant.Annals of transplantation · 2021Article
- Developing a Novel Scoring System for Risk Stratification in Living Donor Liver Transplantation.Journal of clinical medicine · 2021Article
- Ergostatrien-3β-ol (EK100) fromPreventive nutrition and food science · 2021Article
- Incidence and Risk Factors of Alcohol Relapse after Liver Transplantation: Analysis of Pre-Transplant Abstinence and Psychosocial Features.Journal of clinical medicine · 2020Article
- Inferior Outcomes Associated with the Coexistence of Hepatocellular Carcinoma Recurrence and Hepatic Virus Reinfection After Living Donor Liver Transplantation.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2020Article
- Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.The lancet. Gastroenterology & hepatology · 2020Review
- Bilateral proficiency over time leads to reduced donor morbidity in living donor hepatectomy.Hepatobiliary surgery and nutrition · 2019Article
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Taiwan has a high prevalence of hepatitis B and C viral infections, and consequently a high burden of chronic liver diseases. Liver transplantation (LT) began in Taiwan in 1984, and living donor liver transplantation (LDLT) in 1994. Education and collaboration between physicians on a national and international scale were important factors in the development of transplantation in East Asia. Technical innovations in donor hepatectomy, vascular and biliary reconstruction, and interventional radiology, perioperative management of transplant patients and development of associated specialties have enabled achievement of excellent results after both adult and pediatric LDLT. The establishment of rigorous protocols to withstand strict medico-legal scrutiny, combined with technical excellence has contributed to excellent surgical outcomes. The socioeconomic development of Taiwan and the first nationwide hepatitis B vaccination program in the world have also contributed to the decrease in disease burden and improvement of quality of healthcare. This article examines the factors enabling the development of LT in Taiwan, the innovations that have contributed to excellent outcomes, and indicates the future prospects of LDLT in Taiwan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.